Ronald Blue Trust, Inc. Senseonics Holdings, Inc. Transaction History
Ronald Blue Trust, Inc.
- $7.98 Billion
- Q3 2024
A detailed history of Ronald Blue Trust, Inc. transactions in Senseonics Holdings, Inc. stock. As of the latest transaction made, Ronald Blue Trust, Inc. holds 11,975 shares of SENS stock, worth $3,353. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,975
Previous 11,975
-0.0%
Holding current value
$3,353
Previous $4,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding SENS
# of Institutions
142Shares Held
60.3MCall Options Held
393KPut Options Held
254K-
Vanguard Group Inc Valley Forge, PA23.5MShares$6.59 Million0.0% of portfolio
-
Black Rock Inc. New York, NY8.32MShares$2.33 Million0.0% of portfolio
-
Masters Capital Management LLC Atlanta, GA7MShares$1.96 Million0.12% of portfolio
-
Geode Capital Management, LLC Boston, MA5.84MShares$1.63 Million0.0% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA3.06MShares$858,1590.0% of portfolio
About Senseonics Holdings, Inc.
- Ticker SENS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 465,447,008
- Market Cap $130M
- Description
- Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with ...